| 1. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 2. |
NCCN. Clinical Practice Guidelines in Oncology. Gastric Cancer, Version 1.2019. https://www.nccn.org/professionals/physician_gls/default.aspx.
|
| 3. |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer, 2017, 20(1): 1-19.
|
| 4. |
Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2016, 27(suppl 5): v38-v49.
|
| 5. |
Waddell T, Verheij M, Allum W, et al. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2013, 24(Suppl 6): vi57-vi63.
|
| 6. |
日本胃癌學會. 胃癌治療ガイドライン. 5 版. 東京: 金原出版株式會社, 2018.
|
| 7. |
Nakamura K, Katai H, Mizusawa J, et al. A phase Ⅲ study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage ⅠA/ⅠB gastric Cancer (JCOG0912). Jpn J Clin Oncol, 2013, 43(3): 324-327.
|
| 8. |
Kim HH, Han SU, Kim MC, et al. Prospective randomized controlled trial (phase Ⅲ) to comparing laparoscopic distal gastrectomy with open distal gastrectomy for gastric adenocarcinoma (KLASS 01). J Korean Surg Soc, 2013, 84(2): 123-130.
|
| 9. |
Inaki N, Etoh T, Ohyama T, et al. A multi-institutional, prospective, phase Ⅱ feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901). World J Surg, 2015, 39(11): 2734-2741.
|
| 10. |
Katai H, Mizusawa J, Katayama H, et al. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage Ⅰ gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer. 2019 Feb 20. doi: 10.1007/s10120-019-00929-9.
|
| 11. |
Topal B, Leys E, Ectors N, et al. Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma. Surg Endosc, 2008, 22(4): 980-984.
|
| 12. |
Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. International Agency for Research on Cancer (IARC) Press: Lyon, 2000.
|
| 13. |
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg, 1998, 85(11): 1457-1459.
|
| 14. |
Kurokawa Y, Hiki N, Yoshikawa T, et al. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery, 2015, 157(3): 551-555.
|
| 15. |
Yamashita H, Seto Y, Sano T, et al. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer, 2017, 20(Suppl 1): 69-83.
|
| 16. |
Yoshikawa T, Takeuchi H, Hasegaw N, et al. Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamaous cell carcinoma of esophagogastric juction. Gastric Cancer, 2016, 19(1): 143-149.
|
| 17. |
國際食管疾病學會中國分會(CSDE)食管胃結合部疾病跨界聯盟, 中國醫師協會內鏡醫師分會腹腔鏡外科專業委員會, 中國醫師協會外科醫師分會上消化道外科醫師專業委員會, 等. 《食管胃結合部腺癌外科治療中國專家共識(2018年版). 中華胃腸外科雜志, 2018, 21(9): 961-975.
|
| 18. |
Kurokawa Y, Doki Y, Mizusawa J, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol, 2018, 3(7): 460-468.
|
| 19. |
Sano T, Sasako M, Mizusawa J, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg, 2017, 265(2): 277-283.
|
| 20. |
中國胃腸腫瘤外科聯盟, 中國抗癌協會胃癌專業委員會. 中國胃腸腫瘤外科術后并發癥診斷登記規范專家共識(2018版). 中國實用外科雜志, 2018, 38(6): 589-595.
|
1/5
WeChat